Literature DB >> 22512478

A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents.

Hanieh Azimi1, Ali-Asghar Khakshur, Iman Aghdasi, Mehrnaz Fallah-Tafti, Mohammad Abdollahi.   

Abstract

OBJECTIVE: In this paper, we reviewed plants being effective in treatment of BPH for the purpose of finding new sources of pharmaceutical agents.
METHODS: All pertinent literature databases were searched. The search keywords were plant, herb, herbal therapy, phytotherapy, benign prostatic hyperplasia, BPH, and prostate. All of the human, animal and in vitro studies were evaluated.
RESULTS: According to the studies, some of the substantial effective constituents of the plants in treatment of BPH are oenothein B, icaritin, xanthohumol, diarylheptanoid, 2,6,4'-trihydroxy-4-methoxybenzophenone, emodin, fatty acids, atraric acid, n-butylbenzene-sulfonamide, curbicin, theaflavin-3,30-digallate, penta-O-galloyl-b-D-glucose, lycopene, sinalbin, β-sitosterol, secoisolariciresinol diglucoside, genistein, apigenin, baicalein, and daidzein. Besides, Serenoa repens, Pygeum africanum, Curcubita pepo, and Urtica dioica as the most prevalent plants used to treat BPH. S. repens in human studies showed equivalent effectiveness to tamsulosin and in combination to U. dioica revealed equal effects to finastride with less side effects.
CONCLUSION: There are numerous plants that have beneficial influence on BPH although the mechanisms of action in some plants are not well understood yet. Active ingredients of some of these plants are known and can be used as lead components for development of new effective and safe drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22512478     DOI: 10.2174/187152812800392715

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  12 in total

1.  Reducing Virulence and Biofilm of Pseudomonas aeruginosa by Potential Quorum Sensing Inhibitor Carotenoid: Zeaxanthin.

Authors:  Barış Gökalsın; Busecan Aksoydan; Burak Erman; Nüzhet Cenk Sesal
Journal:  Microb Ecol       Date:  2017-03-02       Impact factor: 4.552

2.  Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies.

Authors:  Matthias Oelke; Richard Berges; Sandra Schläfke; Martin Burkart
Journal:  World J Urol       Date:  2014-06-18       Impact factor: 4.226

3.  Lichen secondary metabolite evernic acid as potential quorum sensing inhibitor against Pseudomonas aeruginosa.

Authors:  Barış Gökalsın; Nüzhet Cenk Sesal
Journal:  World J Microbiol Biotechnol       Date:  2016-07-27       Impact factor: 3.312

4.  Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract.

Authors:  George Awuku Asare; Daniel Afriyie; Robert A Ngala; Alfred A Appiah; Yvonne Anang; Iddi Musah; Samuel Adjei; Kwabena Bamfo-Quaicoe; Derick Sule; Ben A Gyan; Peter Arhin; Dominic A Edoh
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-02       Impact factor: 2.629

Review 5.  Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms.

Authors:  Celeste De Monte; Simone Carradori; Arianna Granese; Giovanni Battista Di Pierro; Costantino Leonardo; Cosimo De Nunzio
Journal:  BMC Urol       Date:  2014-08-11       Impact factor: 2.264

6.  In silico profiling for secondary metabolites from Lepidium meyenii (maca) by the pharmacophore and ligand-shape-based joint approach.

Authors:  Fan Yi; Xiao-Lei Tan; Xin Yan; Hai-Bo Liu
Journal:  Chin Med       Date:  2016-09-26       Impact factor: 5.455

7.  Inhibitory effect of rape pollen supercritical CO2 fluid extract against testosterone-induced benign prostatic hyperplasia in rats.

Authors:  Bi-Cheng Yang; Li-Li Jin; Yi-Fang Yang; Kun Li; Dan-Ming Peng
Journal:  Exp Ther Med       Date:  2014-04-14       Impact factor: 2.447

Review 8.  LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals.

Authors:  Miryam Nava Catorce; Goar Gevorkian
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

9.  Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients.

Authors:  George Awuku Asare; Yvonne Anang; Daniel K Afriyie; Brodrick Yeboah Amoah; Bernice Asiedu; Derek Doku; Hannah Serwah Ocansey; Nana Yaw Odei Danso; Prince Tekpor; Sarah Osam
Journal:  Medicines (Basel)       Date:  2017-11-18

10.  Rhodobacter sphaeroides Extract Lycogen™ Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats.

Authors:  Chiang-Ting Wang; Ya-Yun Wang; Wen-Sheng Liu; Chun-Ming Cheng; Kuo-Hsun Chiu; Li-Lian Liu; Xue-Zhu Liu; Zhi-Hong Wen; Ya-Huey Chen; Tsung-Ming Chen
Journal:  Int J Mol Sci       Date:  2018-04-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.